Sumitomo Heavy Industries (TYO:6302) Signs Implementation Agreement For the Proton Therapy System Cancer Treatment Facility With Samsung Medical Centre in Korea
On 15th April, 2011, Sumitomo Heavy Industries Ltd (TYO:6302) (President Yoshinobu NAKAMURA, "Sumitomo Heavy Industries" hereafter) signed the implementation contract for the Proton Therapy System with Samsung Medical Centre (Seoul, Korea), the key hospital of the Samsung Group in Korea.